It has been known for several years that conditions such as chronic primary polydipsia, hypothyroidism, and adrenal disease are associated with abnormalities in urinary concentration and dilution. With the relatively recent discovery of aquaporin water channels and the development of techniques to assess the regulation and function of aquaporins and ion and urea transporters in the kidney, it is now possible to better understand the molecular mechanisms responsible for abnormal urinary concentration and dilution in these conditions. Therefore, the present studies are designed to first correlate alterations in the renal abundance of aquaporin water channels and ion and urea transporters with impaired urinary concentration and dilution in the above-named conditions. This will be accomplished using western immunoblotting techniques. Further investigation into the contributions of altered aquaporin-2 regulation and function to impaired urinary concentration and dilution in these conditions will be performed via a detailed assessment of vasopressin V2 receptor binding and affinity, western immunoblot of inner medulla Gs-alpha and adenylate cyclase abundance, measurement of cAMP production, and evaluation of AQP2 phosphorylation and trafficking. The results of these studies should give us a comprehensive understanding of the mechanisms that contribute to altered urinary concentration and dilution in chronic primary polydipsia, hypothyroidism, and adrenal disease. These results will provide a basis for translational studies addressing these concerns in patients affected by these disorders.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Colorado Denver
United States
Zip Code
Li, Chunling; Wang, Weidong; Rivard, Christopher J et al. (2011) Molecular mechanisms of angiotensin II stimulation on aquaporin-2 expression and trafficking. Am J Physiol Renal Physiol 300:F1255-61
Andres-Hernando, Ana; Lanaspa, Miguel A; Li, Nanxing et al. (2010) Effects of 2-bromoethanamine on TonEBP expression and its possible role in induction of renal papillary necrosis in mice. Toxicol Sci 118:510-20
Furgeson, Seth B; Simpson, Peter A; Park, Insun et al. (2010) Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation. Cardiovasc Res 86:274-82
Wang, Weidong; Li, Chunling; Summer, Sandra et al. (2010) Interaction between vasopressin and angiotensin II in vivo and in vitro: effect on aquaporins and urine concentration. Am J Physiol Renal Physiol 299:F577-84
Schrier, Robert W (2010) Systemic arterial vasodilation, vasopressin, and vasopressinase in pregnancy. J Am Soc Nephrol 21:570-2
Lanaspa, Miguel A; Andres-Hernando, Ana; Rivard, Christopher J et al. (2009) ZAC1 is up-regulated by hypertonicity and decreases sorbitol dehydrogenase expression, allowing accumulation of sorbitol in kidney cells. J Biol Chem 284:19974-81
Schrier, Robert W (2009) Interactions between angiotensin II and arginine vasopressin in water homeostasis. Kidney Int 76:137-9
Berl, Tomas (2009) How do kidney cells adapt to survive in hypertonic inner medulla? Trans Am Clin Climatol Assoc 120:389-401
Bansal, Shweta; Lindenfeld, JoAnn; Schrier, Robert W (2009) Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist? Circ Heart Fail 2:370-6
Schrier, Robert W; Masoumi, Amirali; Elhassan, Elwaleed (2009) Role of vasopressin and vasopressin receptor antagonists in type I cardiorenal syndrome. Blood Purif 27:28-32

Showing the most recent 10 out of 153 publications